Clinical trial analysis of 2019‐nCoV therapy registered in China-Reference-Cited by-同舟云学术

Clinical trial analysis of 2019‐nCoV therapy registered in China

Published:2020-03-05 Issue:6 Volume:92 Page:540-545
ISSN:0146-6615
Container-title:Journal of Medical Virology
language:en
Short-container-title:J Med Virol

Author:

Zhang Qi¹^ORCID,Wang Yakun¹^ORCID,Qi Changsong¹,Shen Lin¹,Li Jian¹^ORCID

Affiliation:

1. Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Gastrointestinal OncologyPeking University Cancer Hospital and InstituteBeijing China

Publisher

Wiley

Subject

Infectious Diseases,Virology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jmv.25733

Reference9 articles.

1. CT Imaging Features of 2019 Novel Coronavirus (2019-nCoV)

2. Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR

3. Cancer patients in SARS‐CoV‐2 infection: a nationwide analysis in China;Liang W;Lancet Oncol,2020

4. SARS: Systematic Review of Treatment Effects

5. High-Throughput Screening and Identification of Potent Broad-Spectrum Inhibitors of Coronaviruses

Cited by 108 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development and preclinical evaluation of equine-derived hyperimmune serum against SARS-CoV-2 infection in K-18 hACE2 transgenic (Tg) mice;Polish Journal of Veterinary Sciences;2024-03-20

2. Back to the Future: Immune Protection or Enhancement of Future Coronaviruses;Microorganisms;2024-03-19

3. A mathematical modeling of COVID-19 treatment strategies utilizing the Laplace Adomian decomposition method;Results in Control and Optimization;2024-03

4. Efficacy and Safety of Tocilizumab Treatment in Tunisian Critically Ill COVID‐19 Patients;Journal of Immunology Research;2024-01

5. Leveraging Nanotechnology for Addressing COVID-19: Revealing Antiviral Approaches and Hurdles;World Journal of Nano Science and Engineering;2024